loading...| Preferred Name |
Etretinate |
|
| Synonyms |
Ethyl-all-trans-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoate (2E,4E,6E,8E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic Acid, Ethyl Ester ETRETINATE Etretinate Ro 10-9359 Tegison Tigason |
|
| Definitions |
A synthetic oral retinoid that is a prodrug of acitretin. Etretinate activates retinoid receptors, causing an induction of cell differentiation, inhibition of cell proliferation, and inhibition of tissue infiltration by inflammatory cells. Etretinate is no longer commercially available in the U.S. due to the extended potential for teratogenic effects related to its long half-life. (NCI04) |
|
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C29036 |
|
| CAS_Registry |
54350-48-0 |
|
| CHEBI_ID |
CHEBI:4913 |
|
| Chemical_Formula |
C23H30O3 |
|
| code |
C29036 |
|
| Concept_In_Subset | ||
| Contributing_Source |
FDA |
|
| DEFINITION |
A synthetic oral retinoid that is a prodrug of acitretin. Etretinate activates retinoid receptors, causing an induction of cell differentiation, inhibition of cell proliferation, and inhibition of tissue infiltration by inflammatory cells. Etretinate is no longer commercially available in the U.S. due to the extended potential for teratogenic effects related to its long half-life. (NCI04) |
|
| FDA_UNII_Code |
65M2UDR9AG |
|
| FULL_SYN |
Ethyl-all-trans-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoate (2E,4E,6E,8E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic Acid, Ethyl Ester ETRETINATE Etretinate Ro 10-9359 Tegison Tigason |
|
| label |
Etretinate |
|
| Legacy Concept Name |
Etretinate |
|
| NSC Number |
297936 |
|
| Preferred_Name |
Etretinate |
|
| prefixIRI |
Thesaurus:C29036 |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C0015137 |
|
| subClassOf |